Newsroom

Industry News

23 Oct

Intellipharmaceutics Reports Positive Results from a Series of Phase I Clinical Trials of Regabatin(TM) XR (Pregabalin Extended-Release)

Intellipharmaceutics International Inc. (IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today provided an update on the progress of its Regabatin(TM) XR product development. Regabatin(TM) XR pregabalin extended release capsules are the Company’s non-generic...

Read more

23 Oct

Arch Therapeutics Negotiating a Collaboration Agreement With CURAM Centre for Research in Medical Devices

Collaboration Agreement Would Provide Additional Technical and Financial Support for Company’s Research and Development Program, Including Clinical and Regulatory Activities Targeting Planned CE Mark  Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of the AC5 Surgical Hemostat™, announced today that it is negotiating a potential collaboration agreement...

Read more

22 Oct

SurePure, Inc. Selects Merriman Capital as Capital Markets Advisor

Merriman Capital, Inc. (“Merriman”), a wholly owned subsidiary of Merriman Holdings, Inc. (MERR), is pleased to announce that it has been selected as Capital Markets Advisor to SurePure, Inc. (SURP). SurePure`s patented technology purifies liquids using UV-C light, in lieu of pasteurization and chemicals, which are traditionally used to...

Read more

22 Oct

United Health Products, Inc. Receives Initial Medicom(R) Order

United Health Products, Inc. (OTCQB: UEEC) announced that its Canadian distributor Medicom has placed an initial sampling and stocking order for the US and Canadian Dental Markets. Medicom®, headquartered in Montreal, Quebec with operations in over 50 countries, is a globally recognized manufacturer and supplier to the Dental and Health...

Read more

22 Oct

GeoVax to Present HIV Vaccine Clinical Trial Data at HIVR4P Conference

GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines using its novel DNA/MVA platform technology, today announced that its Chief Scientific Officer, Harriet L. Robinson, Ph.D., will give an oral presentation at the HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P)...

Read more

21 Oct

Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania Partner to Combat Influenza and Antibiotic Resistant Bacteria

 Inovio Pharmaceuticals, Inc. (INO) announced today the Defense Advanced Research Projects Agency (DARPA) has awarded $12.2 million for a collaborative study that will be conducted by scientists from the Perelman School of Medicine at the University of Pennsylvania; Inovio Pharmaceuticals; and MedImmune, the global biologics research and development arm...

Read more

20 Oct

Matinas BioPharma Submits Investigational New Drug Application for Lead Product Candidate MAT9001 for the Treatment of Severe Hypertriglyceridemia

Matinas BioPharma Holdings, Inc.(“Matinas BioPharma” or the “Company”) (MTNB), an emerging biopharmaceutical company focused on the development and commercialization of omega-3 fatty acid-based prescription therapeutics for the treatment of cardiovascular and metabolic conditions, announced today that the Company has submitted an Investigational New Drug application (IND) for MAT9001 to...

Read more

Page 1 of 2412345...1020...Last »

Latest Tweets